Family with sequence similarity 197 Y-linked member 3 (FAM197Y3)

Family with sequence similarity 197 Y-linked member 3 (FAM197Y3) is listed as a predicted gene on the Y chromosome of the human genome. It is annotated as "family with sequence similarity 197 Y-linked member 3" according to GeneCards, Ensembl, and NCBI Gene. There is no experimental evidence for a protein product, biological function, molecular family, druggability, or disease association. It is not reported as a receptor, enzyme, transporter, or any characterized drug target. There are no reported roles in physiology, disease, or clinical application. Database entries refer to FAM197Y3 mainly as a predicted, uncharacterized gene of the FAM197Y family, and there are no references in the biomedical literature to any biological or therapeutic roles of this gene. While the FAM3 gene family (FAM3A-D) is associated with cytokine-like functions, FAM197Y3 is not part of this well-characterized family; there are no data linking FAM197Y3 to cytokine, immune, oncogenic, or other signaling functions. No aliases, classification, or disease linkages are available past its annotation as an "uncharacterized predicted gene." The only disease-adjacent mention is in the context of studies assessing global Y chromosome gene status in prostate cancer, but no function or role for FAM197Y3 itself is described. There is no evidence that this is a valid or actionable drug target. FAM197Y3 is a Y-linked, uncharacterized, predicted gene without evidence for function, therapeutic targeting, or disease relevance. It should not be considered a true drug/receptor target.

Other names

FAM197Y3